RBC Capital raised the firm’s price target on Teleflex (TFX) to $135 from $130 and keeps a Sector Perform rating on the shares. The company’s Q2 earnings beat alleviates concerns over downside risk amid operational improvements, the analyst tells investors in a research note. Teleflex’s planned business separation remains on track, with management noting continued significant third-party interest in acquiring NewCo, the firm added.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFX:
- Teleflex Reports Strong Q2 2025 Financial Results
- Teleflex’s Strong Q2 Performance and Acquisition Benefits Tempered by Margin Concerns and Uncertainty
- Teleflex price target raised to $135 from $130 at RBC Capital
- Teleflex Raises 2025 Guidance After BIOTRONIK Acquisition
- Teleflex reports Q2 adjusted EPS $3.73, consensus $3.37